Neurology Advisor

FDA Approves Lower-Dose Gadolinium Contrast Agent Ambelvist

The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.

From X-rays to MRI: Five Imaging Tests, Their Differences, and Precautions

Sportschosun, Jang Jong-ho] Imaging tests are a key tool in modern medicine for accurately diagnosing diseases and ...
Healthcare in Europe

Abdominal imaging in pregnancy: Balancing diagnostic accuracy with fetal safety

Imaging pregnant women with acute abdominal pain remains a significant clinical challenge – not only because of concerns ...
Healio

FDA approves Ambelvist MRI contrast agent with lower dose of gadolinium

The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...